MM120 Market Size and Forecast (Anxiety Therapeutics) MM120 (LSD D-Tartrate) is an investigational psychoactive substance primarily being developed for Generalized Anxiety Disorder (GAD). As it is currently in Phase 3 clinical trials,…
Category: Uncategorized
CD Skyrizi Market: Size, Forecast, Drivers, and Key Trends
Skyrizi (Crohn’s Disease) Market Size and Forecast Skyrizi (risankizumab), an IL-23 inhibitor developed by AbbVie, is a major growth driver in the inflammatory bowel disease (IBD) market, particularly for Crohn’s disease (CD)….
Schiz Evenamide Market: Size, Forecast, Drivers, and Key Trends
Evenamide Market Size and Forecast The Evenamide market size is currently based on its potential as an add-on therapy for chronic schizophrenia patients who respond poorly to existing second-generation antipsychotics. As Evenamide…
PsA Skyrizi Market: Size, Forecast, Drivers, and Key Trends
PsA Skyrizi Market Size and Forecast Skyrizi (risankizumab), an interleukin-23 (IL-23) inhibitor developed by AbbVie, has secured a significant position in the Psoriatic Arthritis (PsA) treatment landscape. The drug’s market performance is…
OCD Droxidopa Market: Size, Forecast, Drivers, and Key Trends
Droxidopa Market Size and Forecast The global Droxidopa market is expected to demonstrate substantial growth, driven by its established use in treating symptomatic neurogenic orthostatic hypotension (nOH). The market size was estimated…
Viti Levo Rux Market: Size, Forecast, Drivers, and Key Trends
Viti Levo Rux Market Size and Forecast The Viti Levo Rux market, specializing in next-generation therapeutic compounds, is poised for significant expansion, driven by its application in complex disease management. Current market…
PTSD Blarcamesine Market: Size, Forecast, Drivers, and Key Trends
PTSD Blarcamesine Market Size and Forecast The market for Blarcamesine in Post-Traumatic Stress Disorder (PTSD) is nascent, currently centered on its potential and ongoing clinical development by Anavex Life Sciences. While Blarcamesine…
Sjog Efgartigimod Market: Size, Forecast, Drivers, and Key Trends
Efgartigimod Market Size and Forecast Efgartigimod, marketed as Vyvgart, is an IgG1 Fc fragment approved for generalized Myasthenia Gravis (gMG). Its market size was estimated at approximately USD 2.19 billion in 2024….
AD ALZ-801 Market: Size, Forecast, Drivers, and Key Trends
ALZ-801 Market Size and Forecast ALZ-801 (valiltramiprosate) is positioned within the rapidly evolving Alzheimer’s Disease (AD) therapeutics market, which is projected to reach significant valuations, with the broader AD market expected to…
Behc Infliximab Market: Size, Forecast, Drivers, and Key Trends
Behçet’s Syndrome Infliximab Market Size and Forecast The market for Infliximab in Behçet’s Syndrome (BS) is a niche segment within the broader rheumatology and biologics markets. It focuses on treating severe, refractory…